-
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
03 May 2024 17:21 GMT
… May 2, 2024
Alnylam Pharmaceuticals, Inc. beats earnings … top tier biotech developing and commercializing transformative medicines for … largest treatment effect and will best demonstrate the drug’ … an angiotensin receptor blocker olmesartan. The study achieved …
-
4 Biotech Stocks to Watch Closely in May
30 Apr 2024 13:19 GMT
… biotechnology continues to propel breakthroughs in pharmaceuticals, genomics, and medical … antihypertensive medications: indapamide, amlodipine, or olmesartan.
… developed for hypertension treatment, potentially requiring … PRESERVE 2 trial, testing trilaciclib …
-
3 Biotech Stocks Paving the Way for Bullish Investment Gains
17 Apr 2024 19:03 GMT
… investments in personalized medicine, numerous advancements in … in fundamentally strong biotech stocks Alnylam Pharmaceuticals, Inc. (ALNY … or angiotensin receptor blocker (olmesartan).
Zilebesiran is an … in development for the treatment of hypertension with …
-
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
08 Apr 2024 18:56 GMT
… However, when added to olmesartan, the experimental drug delivered a 4 mmHg … (p=0.26).
Alnylam Pharmaceuticals and its partner Roche Holdings … of 2-4 anti-hypertensive medicines and are planning a … HELIOS-B cardiovascular outcomes trial for vutrisiran in TTR- …
-
Twice-yearly injectable antihypertensive drug lowers BP at 6 months: KARDIA-2
07 Apr 2024 21:38 GMT
… to complex, multi-drug oral treatment regimens may be … olmesartan (n = 301). Those who consistently took those medications … al. Late-breaking clinical trials II. Presented at: … , AstraZeneca, Bayer, Healthcare Pharmaceuticals, Novartis and Pfizer.
Add …
-
Handok hosts symposium, marking launch of hypertension drug Aprovasc
20 Mar 2024 07:22 GMT
… 301 and 302 clinical trials, which served as the … the Gangnam-gu Internal Medicine Association, presided over the … , and better treatment adherence compared to single-drug combination therapy.
… systolic reduction compared to olmesartan. In a European cohort …
-
Alnylam’s experimental drug for high blood pressure yields encouraging results
05 Mar 2024 18:30 GMT
… in statements. The treatment calls for the medicine to be injected twice … of the three medicines -- indapamide, amlodipine, or olmesartan -- were sustained … beginning another trial of the drug as an add-on treatment in adults …
-
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
05 Mar 2024 20:26 GMT
… , Alnylam Pharmaceuticals Inc … angiotensin receptor blocker (olmesartan).
Zilebesiran demonstrated an … treatment with two to four standard of care antihypertensive medications … treatments.
However, investor attention is currently focused on the HELIOS-B trial …
-
Dr Mansukh Mandaviya inaugurates 27 greenfield bulk drug park projects, 13 greenfield manufacturing plants for medical devices under the PLI Scheme
04 Mar 2024 09:34 GMT
… the field of critical medicines and active pharmaceutical ingredients (API), the … Telangana
8
Oxcarbazepine
9
Hetero Drugs Limited
Carbidopa
Visakhapatnam, Andhra Pradesh …
Losartan
Nalgonda, Telangana
18
Olmesartan
19
Andhra Organics Limited
Sulfadiazine …
-
Dr Mansukh Mandaviya inaugurates 51 greenfield projects under PLI scheme for Bulk Drugs and Medical Devices
04 Mar 2024 06:29 GMT
… Department of Pharmaceuticals, Dr Mandaviya said that bulk drugs and medicines are critical … Private Limited
Losartan
Nalgonda, Telangana
Olmesartan
Sadhana Nitro Chem Ltd.
Para …